Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition

New England Journal of Medicine(2020)10.1056/nejmoa1914919Source: DataRank Database

WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition is a research paper published in New England Journal of Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 79 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access79 citations

Download PDF

Cite:

Linked data & code

gen uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: bronzeTopics (36)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Lamis Yehia ORCID,Takahiro Kishikawa ORCID,Ying Ni ORCID,Brandie Heald ORCID,Jinfang Zhang ORCID

Live enrichment

PubMed:32459922 PMC:PMC7839065

National Institutes of Health

Grant: R01 CA82328

National Institutes of Health

Grant: R35 CA197529

National Cancer Institute

Grant: P01CA124570

National Cancer Institute

Grant: R01CA118989

NCI NIH HHS

Grant: R01 CA082328

National Institutes of Health

Grant: 5R01HL118989-04

Glucose And BCAA Metabolism in the Heart

National Institutes of Health

Grant: 5P01CA124570-04

Integrated Clinical Information and Pathology Sample Repository

National Institutes of Health

Grant: 1R35CA197529-01

Targeting Tumor Suppressive Pathways for Cancer Therapy

National Institutes of Health

Grant: 5R01CA082328-15

PTEN and ontogenesis and tumor suppression

bronzeLicense: http://www.nejmgroup.org/legal/terms-of-use.htm

publisherhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa1914919

https://doi.org/10.1056/nejmoa1914919

https://pubmed.ncbi.nlm.nih.gov/32459922

https://dx.doi.org/10.1056/nejmoa1914919

Fields of Study

0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansMiceMice, Mutant StrainsHamartoma Syndrome, MultipleDisease Models, AnimalGenetic Predisposition to DiseaseUbiquitin-Protein LigasesProspective StudiesPedigreeGerm-Line MutationAdultFemaleMalePTEN PhosphohydrolaseGenetic VariationGain of Function Mutation

Keywords

AdultMaleUbiquitin-Protein LigasesPTEN PhosphohydrolaseGenetic VariationMice, Mutant StrainsPedigreeDisease Models, AnimalMiceGain of Function MutationAnimalsHumansFemaleGenetic Predisposition to DiseaseProspective StudiesHamartoma Syndrome, MultipleGerm-Line Mutation

Sustainable Development Goals

SDG 3: 3. Good health

WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition

FAIR Checklist

Authors (11)

Funding (9 grants)

Open Access

Topics

Annotations (Europe PMC)